Prediction: Lilly Will Trade at $1,200 by Year-End
Investors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
Find out when rewards points are truly worth it. Maximize your benefits and learn how to save more on your travels.
15,541 articlesInvestors weigh a bold forecast that Eli Lilly could hit $1,200 by year-end 2026, betting on GLP-1 drugs and a robust...
In 2026, choosing between State Street's XLF and Fidelity's FNCL comes down to breadth versus focus. This guide break...
A major Ethereum Layer-2 network, Taiko, halted block production after an exploit. Blockaid suggests the root cause l...
Bank of America signals three quarter-point rate increases in 2026, rattling lenders and borrowers alike. Here’s what...
In mid-2026, demand dynamics are reasserting themselves as the key driver behind housing trends. With supply still co...
Emerging markets can boost growth, but they come with unique risks. This guide explains what to consider before addin...
If you want broad exposure to the U.S. stock market without paying hefty fees, two giants dominate the scene. This gu...
Apple hikes prices on Macs and iPads amid a sharp rise in memory chip costs driven by AI infrastructure demand. The m...
When spacex dipped below $150, the move drew attention from patient investors who study psychology, risk, and value. ...
Analysts say Bitcoin’s price cycles show a repeatable cadence. With a high in October 2025 and a window around Octobe...
Stocks climbed on Monday after weekend actions in the Middle East, extending a pattern investors have watched in seve...
A surprising gift disclosure involving a music label and a Supreme Court justice reveals the money-side of public tra...